FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
- Posted on June 18, 2026
- By The Toronto Star
- 0 Views
- 1 min read
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
WASHINGTON (AP) — U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19
